31/03/2026 Other Services
Randomised Controlled Trials (RCTs), particularly Phase III clinical trials, have long been considered the gold standard in medical research. They provide the foundational data required for regulatory approval, demonstrating that a new therapy is both safe and efficacious under strictly controlled conditions. However, the journey of a pharmaceutical product does not end with regulatory approval. In fact, understanding how a treatment performs in the general population begins only after it enters the market. This is where Real World Evidence Studies become indispensable.
Randomised Controlled Trials (RCTs), particularly Phase III clinical trials, have long been considered the gold standard in medical research. They pro...
The landscape of clinical research has expanded significantly beyond the controlled environment of randomised clinical trials. As the industry seeks t...
India’s pharmaceutical industry is changing fast. Patients are more informed. Regulators expect stronger proof. Healthcare systems are focusing on out...
The journey of bringing a new drug or therapy to market is a complex and arduous one, marked by stringent regulatory oversight and significant scienti...
More Details